Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 500-020-4 | CAS number: 9005-67-8 1 - 6.5 moles ethoxylated
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Gene mutation in vitro:
Ames test:
Gene mutation toxicity study was performed to determine the mutagenic nature of the test chemical. The study was performed using Salmonella typhimurium strains TA98 and TA100 in the presence and absence of S9 metabolic activation system. The test chemical was dissolved in distilled water or DMSO as the solvent and used at dose level of 0, 10, 100, 200, 1000 or 2000 µg/plate. The exposure duration was 48 hrs at 37˚C. Concurrent solvent and negative control chemicals were also included in the study. The test chemical did not induce gene mutation in Salmonella typhimurium strains TA98 and TA100 in the presence and absence of S9 metabolic activation system and hence it is not likely to classify as a gene mutant in vitro.
Chromosome aberration assay:
In vitro mammalian chromosome aberration test was performed to evaluate the mutagenic nature of the test chemical. The study was performed using Chinese hamster fibroblast cell line (CHL) cell line. The test chemical was dissolved in physiological saline and used at dose level of 0.20 mg/mL. Three different doses, including the 50% inhibition dose of each agent, which was estimated by the growth inhibition test described above, were prepared and separately added to 3-day-old cultures (about 105cells/6-cm dish). Chromosome preparations were made, as a rule at 24 and 48 h, or when necessary at 6 h, after the treatment. Cells were treated with colcemid (0.2µg/ml) for 2 h, and after trypsinization, they were incubated in 0.075 M KC1 hypotonic solution for 15 rain at 37°C. The cells were fixed with ice-cold fixative (methanol : glacial acetic acid, 3 : 1 v/v) which was changed 3 times. A few drops of the suspension were then placed on clean dry slides which were held horizontally under an electric heater. The slides were stained with 1% Giemsa's buffered solution (pH 6.8) for 20 min. The number of cells with chromosomal aberrations was recorded on 100 well-spread metaphases at the magnification of 700. Types of aberration were classified into 5 groups: chromatid gaps (g), chromatid breaks (b), chromatid or chromosomal translocation (t), ring formation (r) and fragmentation or pulverization (f). Breaks less than the width of a sister chromatid were designated as gaps in our criteria. The incidence of polyploid cells was also calculated. Untreated cells and cells treated only with solvent served as controls. Based on the observations made, the test chemical did not induce chromosomal aberration in Chinese hamster fibroblast cell line (CHL) and hence is it is not likely to classify as a gene mutant in vitro.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Justification for type of information:
- Data is from peer reviewed publication
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Principles of method if other than guideline:
- Gene mutation toxicity study was performed to determine the mutagenic nature of the test chemical
- GLP compliance:
- not specified
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- Histidine
- Species / strain / cell type:
- S. typhimurium, other: TA98 and TA100
- Details on mammalian cell type (if applicable):
- Not applicable
- Additional strain / cell type characteristics:
- not specified
- Cytokinesis block (if used):
- No data
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 metabolic activation system
- Test concentrations with justification for top dose:
- 0, 10, 100, 200, 1000 or 2000 µg/plate
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: The test chemical was soluble in DMSO - Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- not specified
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- benzo(a)pyrene
- other: N-Methyl-N’-nitro-N-nitrosoguanidine, 2-Acetylaminofluorene, N-Nitrosodimethylamine
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: preincubation
DURATION
- Preincubation period: 20 mins
- Exposure duration: 48 hrs
- Expression time (cells in growth medium): 48 hrs
- Selection time (if incubation with a selection agent): No data
- Fixation time (start of exposure up to fixation or harvest of cells): No data
SELECTION AGENT (mutation assays): No data
SPINDLE INHIBITOR (cytogenetic assays): No data
STAIN (for cytogenetic assays): No data
NUMBER OF REPLICATIONS: No data
NUMBER OF CELLS EVALUATED: No data
DETERMINATION OF CYTOTOXICITY
- Method: mitotic index; cloning efficiency; relative total growth; other: No data
OTHER EXAMINATIONS:
- Determination of polyploidy: No data
- Determination of endoreplication: No data
- Other: No data
OTHER: No data - Rationale for test conditions:
- No data
- Evaluation criteria:
- The plates were observed or a dose dependent increase in the number of revertants/plate
- Statistics:
- No data
- Species / strain:
- S. typhimurium, other: TA98 and TA100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Additional information on results:
- No data
- Remarks on result:
- other: No mutagenic potential
- Conclusions:
- The test chemical did not induce gene mutation in Salmonella typhimurium strains TA98 and TA100 in the presence and absence of S9 metabolic activation system and hence it is not likely to classify as a gene mutant in vitro.
- Executive summary:
Gene mutation toxicity study was performed to determine the mutagenic nature of the test chemical. The study was performed using Salmonella typhimurium strains TA98 and TA100 in the presence and absence of S9 metabolic activation system. The test chemical was dissolved in distilled water or DMSO as the solvent and used at dose level of 0, 10, 100, 200, 1000 or 2000 µg/plate. The exposure duration was 48 hrs at 37˚C. Concurrent solvent and negative control chemicals were also included in the study. The test chemical did not induce gene mutation in Salmonella typhimurium strains TA98 and TA100 in the presence and absence of S9 metabolic activation system and hence it is not likely to classify as a gene mutant in vitro.
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Justification for type of information:
- Data is from peer reviewed publication
- Qualifier:
- according to guideline
- Guideline:
- other: Refer below principle
- Principles of method if other than guideline:
- In vitro mammalian chromosome aberration test was performed to evaluate the mutagenic nature of the test chemical
- GLP compliance:
- not specified
- Type of assay:
- other: In vitro mammalian chromosome aberration test
- Target gene:
- No data
- Species / strain / cell type:
- mammalian cell line, other: Chinese hamster fibroblast cell line (CHL)
- Details on mammalian cell type (if applicable):
- - Type and identity of media: The cells had been maintained by 5-day passages and grown in a monolayer in petri dishes with Eagle's MEM (GIBCO F-11) supplemented with 10% calf serum. Their doubling time was estimated as 18.2 h at their exponential growth at 37°C in a 5% CO2 atmosphere.
- Properly maintained: Yes, The cells had been maintained by 5-day passages
- Periodically checked for Mycoplasma contamination: Yes
- Periodically checked for karyotype stability: No data
- Periodically "cleansed" against high spontaneous background: No data - Additional strain / cell type characteristics:
- not specified
- Cytokinesis block (if used):
- No data
- Metabolic activation:
- not specified
- Metabolic activation system:
- No data
- Test concentrations with justification for top dose:
- Maximum dose: 0.20 mg/mL
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: physiological saline (S)
- Justification for choice of solvent/vehicle: The test chemical was soluble in physiological saline - Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- yes
- Remarks:
- Physiological saline
- True negative controls:
- not specified
- Positive controls:
- yes
- Positive control substance:
- not specified
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: In medium
Cells at the start of test: 105 cells/6-cm dish
DURATION
- Preincubation period: No data
- Exposure duration: 48 hrs
- Expression time (cells in growth medium): 48 hrs
- Selection time (if incubation with a selection agent): No data
- Fixation time (start of exposure up to fixation or harvest of cells): No data
SELECTION AGENT (mutation assays): No data
SPINDLE INHIBITOR (cytogenetic assays): Colcemid
STAIN (for cytogenetic assays): Giemsa
NUMBER OF REPLICATIONS: Duplicate
NUMBER OF CELLS EVALUATED: The number of cells with chromosomal aberrations was recorded on 100 well-spread metaphases at the magnification of 700.
DETERMINATION OF CYTOTOXICITY
- Method: mitotic index; cloning efficiency; relative total growth; other: Yes, Aliquots were removed for determination of cell count and viability assessment via the trypan blue exclusion
Test. Mitotic index was also determined
OTHER EXAMINATIONS:
- Determination of polyploidy: No data
- Determination of endoreplication: No data
- Other: No data
OTHER: The cells were fixed with ice-cold fixative (methanol : glacial acetic acid, 3 : 1 v/v) which was changed 3 times. A few drops of the suspension were then placed on clean dry slides which were held horizontally under an electric heater. The slides were stained with 1% Giemsa's buffered solution (pH 6.8) for 20 min. - Rationale for test conditions:
- No data
- Evaluation criteria:
- Types of aberration were classified into 5 groups: chromatid gaps (g), chromatid breaks (b), chromatid or chromosomal translocation (t), ring formation (r) and fragmentation or pulverization (f). Breaks less than the width of a sister chromatid were designated as gaps
CHL cells commonly have less than 3.0% cells with chromosomal aberrations. Therefore, the final judgement given to all experimental groups was asfollows. Negative (--) if less than 4.9% of the aberration was detected even when doses of the agent were elevated to sub-lethal amounts, where almost nomitosis was observed; suspicious (+) if between 5.0 and 9.9%, and positive if between 10.0 and 19.9% (+), 20.0 and 49.9% (++) or more than 50.0% (+++). When no reasonable dose response was obtained, additional experiments with different doses were carried out to confirm its reproducibility - Statistics:
- No data
- Species / strain:
- mammalian cell line, other: Chinese hamster fibroblast cell line (CHL)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- not specified
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Additional information on results:
- No data
- Remarks on result:
- other: No mutagenic potential
- Conclusions:
- The test chemical did not induce chromosomal aberration in Chinese hamster fibroblast cell line (CHL) and hence is it is not likely to classify as a gene mutant in vitro.
- Executive summary:
In vitro mammalian chromosome aberration test was performed to evaluate the mutagenic nature of the test chemical. The study was performed using Chinese hamster fibroblast cell line (CHL) cell line. The test chemical was dissolved in physiological saline and used at dose level of 0.20 mg/mL. Three different doses, including the 50% inhibition dose of each agent, which was estimated by the growth inhibition test described above, were prepared and separately added to 3-day-old cultures (about 105cells/6-cm dish). Chromosome preparations were made, as a rule at 24 and 48 h, or when necessary at 6 h, after the treatment. Cells were treated with colcemid (0.2µg/ml) for 2 h, and after trypsinization, they were incubated in 0.075 M KC1 hypotonic solution for 15 rain at 37°C. The cells were fixed with ice-cold fixative (methanol : glacial acetic acid, 3 : 1 v/v) which was changed 3 times. A few drops of the suspension were then placed on clean dry slides which were held horizontally under an electric heater. The slides were stained with 1% Giemsa's buffered solution (pH 6.8) for 20 min. The number of cells with chromosomal aberrations was recorded on 100 well-spread metaphases at the magnification of 700. Types of aberration were classified into 5 groups: chromatid gaps (g), chromatid breaks (b), chromatid or chromosomal translocation (t), ring formation (r) and fragmentation or pulverization (f). Breaks less than the width of a sister chromatid were designated as gaps in our criteria. The incidence of polyploid cells was also calculated. Untreated cells and cells treated only with solvent served as controls. Based on the observations made, the test chemical did not induce chromosomal aberration in Chinese hamster fibroblast cell line (CHL) and hence is it is not likely to classify as a gene mutant in vitro.
Referenceopen allclose all
Table 1. Mutagenicity of the test compound and the respective control chemicals
Compound |
Dose (µg/plate) |
No. of His+ revertants/plate |
|||
TA100 |
TA98 |
||||
-S9 |
+S9 |
-S9 |
+S9 |
||
Distilled water |
- |
145 |
137 |
19 |
32 |
DMSO |
- |
151 |
141 |
23 |
28 |
4-Nitroquinoline 1-oxide |
0.5 |
1588 |
148 |
167 |
36 |
Benzo[a]pyrene |
2 |
4152 |
128 |
27 |
30 |
2-Acetylaminofluorene |
5 |
178 |
928 |
35 |
614 |
N-Nitrosodimethylamine |
50 |
128 |
1080 |
18 |
2292 |
Test chemical |
10 |
121 |
111 |
18 |
31 |
100 |
134 |
127 |
23 |
29 |
|
200 |
157 |
13 |
33 |
34 |
|
1000 |
148 |
141 |
22 |
33 |
|
2000 |
115 |
136 |
24 |
33 |
Table: Summary of chromosome aberration assay results
Chemical |
Solvent |
Maximum dose (mg/mL) |
Chromosomal aberration test |
|||
% |
Time |
Type |
Judge |
|||
Test chemical |
Physiological saline |
0.20 |
1.0 |
48 |
Chromatid breaks |
- |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Gene mutation in vitro:
Data available for the target chemical was reviewed to determine the mutagenic nature of Sorbitan monostearate, ethoxylated (CAS no 9005 -67 -8). The studies are as mentioned below:
Gene mutation toxicity study was performed to determine the mutagenic nature of the test chemical. The study was performed using Salmonella typhimurium strains TA98 and TA100 in the presence and absence of S9 metabolic activation system. The test chemical was dissolved in distilled water or DMSO as the solvent and used at dose level of 0, 10, 100, 200, 1000 or 2000 µg/plate. The exposure duration was 48 hrs at 37˚C. Concurrent solvent and negative control chemicals were also included in the study. The test chemical did not induce gene mutation in Salmonella typhimurium strains TA98 and TA100 in the presence and absence of S9 metabolic activation system and hence it is not likely to classify as a gene mutant in vitro.
In vitro mammalian chromosome aberration test was performed to evaluate the mutagenic nature of the test chemical. The study was performed using Chinese hamster fibroblast cell line (CHL) cell line. The test chemical was dissolved in physiological saline and used at dose level of 0.20 mg/mL. Three different doses, including the 50% inhibition dose of each agent, which was estimated by the growth inhibition test described above, were prepared and separately added to 3-day-old cultures (about 105cells/6-cm dish). Chromosome preparations were made, as a rule at 24 and 48 h, or when necessary at 6 h, after the treatment. Cells were treated with colcemid (0.2µg/ml) for 2 h, and after trypsinization, they were incubated in 0.075 M KC1 hypotonic solution for 15 rain at 37°C. The cells were fixed with ice-cold fixative (methanol : glacial acetic acid, 3 : 1 v/v) which was changed 3 times. A few drops of the suspension were then placed on clean dry slides which were held horizontally under an electric heater. The slides were stained with 1% Giemsa's buffered solution (pH 6.8) for 20 min. The number of cells with chromosomal aberrations was recorded on 100 well-spread metaphases at the magnification of 700. Types of aberration were classified into 5 groups: chromatid gaps (g), chromatid breaks (b), chromatid or chromosomal translocation (t), ring formation (r) and fragmentation or pulverization (f). Breaks less than the width of a sister chromatid were designated as gaps in our criteria. The incidence of polyploid cells was also calculated. Untreated cells and cells treated only with solvent served as controls. Based on the observations made, the test chemical did not induce chromosomal aberration in Chinese hamster fibroblast cell line (CHL) and hence is it is not likely to classify as a gene mutant in vitro.
The negative results for bacterial reverse mutation assay and chromosomal aberration assay is further suppoerted by the data from mammalian cell transformation assay study.
In vitro mammalian cell transformation assay was performed to determine the mutagenic nature of the test chemical. The test chemical was dissolved in DMSO as the solvent and used at dose level of 0, 0.01, 0.05, 0.1, 0.5, 1, 5, 10, 20, 50, 100 or 300 µg/mL. Pregnant Syrian golden hamsters were killed on days 13 and 14 of gestation for preparation of target cells and feeder-layer cells respectively. Embryos without heads and viscera were minced with scissors, and trypsinized with 0.25% trypsin. Inocula of 10000000 embryo cells per 75-cm’ flask were incubated at 37°C in a humidified atmosphere of 10% CO2 in air. When they became confluent primary cultures were trypsinized, dispensed in lots of 5000000 cells in glass ampules, and stored in liquid nitrogen for use as target and feeder-layer cells. The assay takes 15 days from start to finish. On Day 0, an ampule of cryopreserved primary cells prepared as feeder-layer cells was rapidly thawed and plated in a 75-cm2flask containing 20 ml of the culture medium. The medium was changed every day. On day 3, an ampule of cryopreserved primary cells prepared as target cells was also rapidly thawed and plated in a 75-cm2flask. On day 4, the feeder cells which were shifting from a stage of logarithmic growth to a stationary phase were irradiated with 5000 R from a linear accelerator, trypsinized, and then plated at 6 x 104tells/60-mm dish in 2 ml of complete medium. On day 5, the target cells which were approximately 80 -90% confluent were trypsinized, and a suspension of 500 target cells in 2 ml of complete medium was then added to each of the dishes plated the day before with irradiated feeder-layer cells. On day 6, an appropriate dose of the test chemical in a volume of 4 ml was added, giving a total volume of 8 ml of medium in each dish. Nine dishes were used for each dose level in all the experiments (in a few cases only eight or seven dishes were used for controls). On day 14, the cultures were fixed with absolute methanol for 10min and stained with Giemsa solution for 45 min or more. The stained dishes were examined with a stereoscopic dissection microscope to count normal and transformed colonies. The exposure duration was 8 days. Concurrent solvent and negative control chemicals were also included in the study. The test chemical did not induce cell transformation in the Pregnant Syrian golden hamsters embryo cell line used and hence it is not likely to classify as a gene mutant in vitro.
Gene mutation toxicity study was performed to determine the mutagenic nature of the test chemical. The study was perfomed using Salmonella typhimurium strains TA98 and TA 100 in the presence and absence of S9 metabolic activation system. The test chemical was dissolved DMSO as the solvent and used at dose level of 0, 10, 100 or 1000µg/plate. The exposure duration was 48 hrs at 37˚C. Concurrent solvent and positive control chemicals were also included in the study. The test chemical did not induce gene mutation in Salmonella typhimurium strains TA98 and TA100 in the presence and absence of S9 metabolic activation system and hence it is not likely to classify as a gene mutant in vitro.
Rec assay was also performed to determine the mutagenic nature of the test chemical. The study was performed using Bacillus subtilis H17 and M45. The test chemical was dissolved in DMSO and used at dose level of 0, 0.05, 0.5 or 5.0 mg/disk. The disk was 8 mm in diameter. The strain was placed so as to cover the starting point of the strain, cultured overnight at 37 ° C. The length of growth inhibition zone of both strains was measured. Concurrent solvent and negative control plates were also included in the study. The test chemical did not induce growth inhibition in Bacillus subtilis H17 and M45 and hence it is not likely to classify as a gene mutant in vitro.
In another study, Gene mutation toxicity study was performed to determine the mutagenic nature of the test chemical. The test chemical was dissolved in distilled water or DMSO as the solvent and used at dose level of 0, 10, 100, 200, 1000 or 5000 µg/plate in experiment 1, 2 and 3. Concurrent solvent and negative control chemicals were also included in the study. The test chemical did not induce gene mutation in Salmonella typhimurium strains TA98 and TA100 in the presence and absence of rat, hamster and guinea pig isolated S9 metabolic activation system and also in the presence and absence of norharman and hence it is not likely to classify as a gene mutant in vitro.
Based on the data available for the test chemical, Sorbitan monostearate, ethoxylated (CAS no 9005 -67 -8) does not exhibit gene mutation in vitro. Hence the test chemical is not likely to classify as a gene mutant in vitro. The negative results of the bacterial reverse mutation assay and chromosomal aberration study are also supported by the the negative results of the in vitro mammalian cell transformation assay indicating the non-mutagenic nature of the test chemical as per the criteria mentioned in CLP regulation.
Justification for classification or non-classification
Based on the data available for the test chemical, Sorbitan monostearate, ethoxylated (CAS no 9005 -67 -8) does not exhibit gene mutation in vitro. Hence the test chemical is not likely to classify as a gene mutant in vitro. The negative results of the bacterial reverse mutation assay and chromosomal aberration study are also supported by the the negative results of the in vitro mammalian cell transformation assay indicating the non-mutagenic nature of the test chemical as per the criteria mentioned in CLP regulation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.